Cyclacel Pharmaceuticals Inc Net Asset Quality Index
Cyclacel Pharmaceuticals Inc net asset quality index. Cyclacel Pharmaceuticals Inc (CYCC) has a Net Asset Quality Index of 82.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $4.40K minus total liabilities of $770.00 yields net assets of $3.63K. A higher index indicates a stronger, lower-leverage balance sheet. See CYCC net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Cyclacel Pharmaceuticals Inc (2000–2024)
Net asset quality index of Cyclacel Pharmaceuticals Inc from 2000 to 2024. This chart shows how Cyclacel Pharmaceuticals Inc's Net Asset Quality Index has evolved across 25 annual periods from 2000 to 2024. As of June 2025, the index stands at 82.5%, representing net assets of $3.63K against total assets of $4.40K USD. Check strategic asset allocation of Cyclacel Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Cyclacel Pharmaceuticals Inc Net Asset Quality Index by Year (2000–2024)
Cyclacel Pharmaceuticals Inc net asset quality index by year from 2000 to 2024. The table below presents the year-by-year Net Asset Quality Index for Cyclacel Pharmaceuticals Inc from 2000 to 2024, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Cyclacel Pharmaceuticals Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -53.1% | $-2.17 Million | $4.09 Million | $6.27 Million | ▼ -60.0 pp |
| 2023 | 6.9% | $607.00K | $8.80 Million | $8.20 Million | ▼ -66.0 pp |
| 2022 | 72.8% | $20.43 Million | $28.05 Million | $7.62 Million | ▼ -14.5 pp |
| 2021 | 87.4% | $37.69 Million | $43.14 Million | $5.44 Million | ▼ -3.0 pp |
| 2020 | 90.4% | $33.26 Million | $36.80 Million | $3.54 Million | ▲ +14.0 pp |
| 2019 | 76.4% | $11.70 Million | $15.31 Million | $3.61 Million | ▼ -0.6 pp |
| 2018 | 77.0% | $15.27 Million | $19.82 Million | $4.55 Million | ▼ -6.7 pp |
| 2017 | 83.7% | $21.77 Million | $26.00 Million | $4.24 Million | ▲ +11.1 pp |
| 2016 | 72.6% | $14.27 Million | $19.66 Million | $5.39 Million | ▼ -3.5 pp |
| 2015 | 76.1% | $18.84 Million | $24.76 Million | $5.93 Million | ▲ +2.3 pp |
| 2014 | 73.8% | $21.69 Million | $29.39 Million | $7.70 Million | ▼ -5.1 pp |
| 2013 | 78.9% | $28.02 Million | $35.52 Million | $7.50 Million | ▲ +27.1 pp |
| 2012 | 51.8% | $10.02 Million | $19.35 Million | $9.34 Million | ▼ -23.2 pp |
| 2011 | 75.0% | $19.50 Million | $26.00 Million | $6.50 Million | ▼ -4.2 pp |
| 2010 | 79.2% | $24.92 Million | $31.46 Million | $6.54 Million | ▲ +47.1 pp |
| 2009 | 32.1% | $4.64 Million | $14.47 Million | $9.82 Million | ▼ -34.6 pp |
| 2008 | 66.7% | $20.64 Million | $30.96 Million | $10.31 Million | ▼ -9.7 pp |
| 2007 | 76.4% | $57.97 Million | $75.91 Million | $17.94 Million | ▼ -8.8 pp |
| 2006 | 85.2% | $53.92 Million | $63.28 Million | $9.36 Million | ▲ +17.1 pp |
| 2005 | 68.1% | $14.60 Million | $21.45 Million | $6.84 Million | ▼ -11.3 pp |
| 2004 | 79.3% | $44.12 Million | $55.60 Million | $11.48 Million | ▲ +429.9 pp |
| 2003 | -350.5% | $-64.84 Million | $18.50 Million | $83.34 Million | ▼ -127.1 pp |
| 2002 | -223.5% | $-48.12 Million | $21.54 Million | $69.66 Million | ▼ -76.8 pp |
| 2001 | -146.6% | $-36.26 Million | $24.73 Million | $60.99 Million | ▼ -57.5 pp |
| 2000 | -89.1% | $-25.38 Million | $28.48 Million | $53.86 Million | — |